A new Nature Metabolism study reports that lipid mixtures in ovarian cancer ascites can blunt anti-tumor T cell responses by disrupting T cell receptor (TCR) dynamics, rather than acting like a simple checkpoint block. The work links dysfunctional T cell activation in the peritoneal fluid microenvironment to physical and biophysical effects on TCR behavior at the cell membrane. The findings sharpen the focus on how tumor-derived or tumor-conditioned components shape immunotherapy resistance. For drug developers, the study adds a mechanistic rationale for targeting tumor microenvironment properties that govern immune synapse formation and signaling competence. Researchers also highlight the clinical relevance by studying materials derived from patients’ ascites, connecting lab readouts to the biochemical complexity of the disease setting.